远程医疗公司Hims & Hers Health Inc.（股票代码：HIMS）在盘后交易中股价大幅下跌10.77%，引发投资者广泛关注。
据悉，Hims & Hers Health正面临一项严重的证券集体诉讼。该公司被指控推广和销售非法版本的减肥药Wegovy，这些药品据称由不受监管的外国供应商制造。这一行为不仅涉嫌违法，还可能危及患者安全。更令投资者担忧的是，原本与Hims & Hers Health建立合作关系的Novo Nordisk公司已宣布终止双方的合作。
这一系列负面消息严重打击了投资者信心。市场分析人士指出，诉讼风险和重要合作伙伴的流失可能会对公司的声誉和未来业务发展造成重大影响。值得注意的是，该集体诉讼鼓励在2025年4月29日至6月23日期间购买Hims & Hers Health证券的投资者参与，申请担任首席原告的截止日期为2025年8月25日。投资者将密切关注此案的进展及其对公司运营的潜在影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.